Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: A matched, retrospective cohort study

J Am Acad Dermatol. 2023 Jun;88(6):1396-1397. doi: 10.1016/j.jaad.2023.02.028. Epub 2023 Feb 25.
No abstract available

Keywords: deep venous thrombosis; doxycycline; minocycline; pulmonary embolism; spironolactone; tetracycline; venous thromboembolism.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acne Vulgaris* / complications
  • Acne Vulgaris* / drug therapy
  • Humans
  • Pulmonary Embolism* / etiology
  • Retrospective Studies
  • Risk Factors
  • Spironolactone / adverse effects
  • Venous Thromboembolism* / epidemiology
  • Venous Thromboembolism* / prevention & control
  • Venous Thrombosis*

Substances

  • Spironolactone